In the preliminary results of its Japanese Phase 3 trial, the percentage change from baseline in LDL-C at Week 12, the primary endpoint, was -25.25 percent in the group receiving bempedoic acid ...
The Browser cookies are disabled and you will not be able to Login to Polymerupdate. Please enable the cookies from the Browser settings by following the instructions ...